TY - JOUR
T1 - The effect of care pathways for hip fractures: a systematic review
AU - Leigheb, F
AU - Vanhaecht, K
AU - Sermeus, W
AU - Lodewijckx, C
AU - Deneckere, S
AU - Boonen, S
AU - PA, Boto
AU - RV, Mendes
AU - PANELLA, Massimiliano
N1 - Funding Information:
This study was supported by the European Pathway Association ( www.E-P-A.org ) through an unrestricted educational grant from Pfizer. We hereby acknowledge Pfizer Belgium, Pfizer Italy, Pfizer Ireland, and Pfizer Portugal for providing the unrestricted educational grant. The funding sources played no role in the design, execution, and evaluation of the present study. S. B. is senior clinical investigator of the Fund for Scientific Research, Flanders, Belgium (F.W.O.-Vlaanderen) and holder of the Leuven University Chair in Gerontology and Geriatrics.
PY - 2012
Y1 - 2012
N2 - We performed a systematic review for primary studies on care pathways (CPs) for hip fracture (HF). The online databases MEDLINE-PubMed, Ovid-EMBASE, CINAHL-EBSCO host, and The Cochrane Library (Cochrane Central Register of Clinical Trials, Health Technology Assessment Database, NHS Economic Evaluation Database) were searched. Two researchers reviewed the literature independently. Primary studies that met predefined inclusion criteria were assessed for their methodological quality. A total of 15 publications were included: 15 primary studies corresponding with 12 main investigations. Primary studies were evaluated for clinical outcomes, process outcomes, and economic outcomes. The studies assessed a wide range of outcome measures. While a number of divergent clinical outcomes were reported, most studies showed positive results of process management and health-services utilization. In terms of mortality, the results provided evidence for a positive impact of CPs on in-hospital mortality. Most studies also showed a significantly reduced risk of complications, including medical complications, wound infections, and pressure sores. Moreover, time-span process measures showed that an improvement in the organization of care was achieved through the use of CPs. Conflicting results were observed with regard to functional recovery and mobility between patients treated with CPs compared to usual care. Although our review suggests that CPs can have positive effects in patients with HF, the available evidence is insufficient for formal recommendations. There is a need for more research on CPs with selected process and outcome indicators, for in-hospital and postdischarge management of HF, with an emphasis on well-designed randomized trials
AB - We performed a systematic review for primary studies on care pathways (CPs) for hip fracture (HF). The online databases MEDLINE-PubMed, Ovid-EMBASE, CINAHL-EBSCO host, and The Cochrane Library (Cochrane Central Register of Clinical Trials, Health Technology Assessment Database, NHS Economic Evaluation Database) were searched. Two researchers reviewed the literature independently. Primary studies that met predefined inclusion criteria were assessed for their methodological quality. A total of 15 publications were included: 15 primary studies corresponding with 12 main investigations. Primary studies were evaluated for clinical outcomes, process outcomes, and economic outcomes. The studies assessed a wide range of outcome measures. While a number of divergent clinical outcomes were reported, most studies showed positive results of process management and health-services utilization. In terms of mortality, the results provided evidence for a positive impact of CPs on in-hospital mortality. Most studies also showed a significantly reduced risk of complications, including medical complications, wound infections, and pressure sores. Moreover, time-span process measures showed that an improvement in the organization of care was achieved through the use of CPs. Conflicting results were observed with regard to functional recovery and mobility between patients treated with CPs compared to usual care. Although our review suggests that CPs can have positive effects in patients with HF, the available evidence is insufficient for formal recommendations. There is a need for more research on CPs with selected process and outcome indicators, for in-hospital and postdischarge management of HF, with an emphasis on well-designed randomized trials
KW - Care pathway
KW - Clinical pathway
KW - Critical pathway
KW - Endocrinology
KW - Endocrinology, Diabetes and Metabolism
KW - Health Care Surveys
KW - Hip Fractures
KW - Hip fractures
KW - Hospital Mortality
KW - Hospitals
KW - Humans
KW - Orthopedics and Sports Medicine
KW - Outcome Assessment (Health Care)
KW - Outcome and process assessment
KW - Systematic review
KW - United States
KW - Care pathway
KW - Clinical pathway
KW - Critical pathway
KW - Endocrinology
KW - Endocrinology, Diabetes and Metabolism
KW - Health Care Surveys
KW - Hip Fractures
KW - Hip fractures
KW - Hospital Mortality
KW - Hospitals
KW - Humans
KW - Orthopedics and Sports Medicine
KW - Outcome Assessment (Health Care)
KW - Outcome and process assessment
KW - Systematic review
KW - United States
UR - https://iris.uniupo.it/handle/11579/12937
U2 - 10.1007/s00223-012-9589-2
DO - 10.1007/s00223-012-9589-2
M3 - Article
SN - 0171-967X
VL - 91
SP - 1
EP - 14
JO - Calcified Tissue International
JF - Calcified Tissue International
IS - 1
ER -